Delivery Order SPE2DB22D3301-SPE2DB25FX3ZX

Award Date 10/18/24
Potential Completion Date 11/8/24
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VENCLEXTA 100 MG TABLET, a medication, with a firm fixed price of $9,728.17 and a period of performance through July 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,748.24 delivery order contract is for the supply of VENCLEXTA 100 MG TABLET medication with an ultimate completion date of January 9, 2025. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,728.17 firm fixed-price contract is for the delivery of 4,567,503,935 units of the drug Venclexta 100 mg tablets. The contract has an ultimate completion date of March 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a specific pharmaceutical product, VENCLEXTA 100 MG TABLET UU 120S, with a ceiling value of $9,728.17. The contract is not set aside and has an ultimate completion date of May 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This contract award, valued at $17,760.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of VENCLEXTA 100 MG TABLET UU 120S, a pharmaceutical product. The contract has an ultimate completion date of September 23, 2024 and was awarded on August 30, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation. As a major supplier of pharmaceutical products and medical supplies to...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,187.06 firm fixed-price delivery order is for VENCLEXTA 100 MG TABLET UU 120S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,728.17 firm-fixed-price delivery order is for the supply of VENCLEXTA 100 MG TABLET UU 120S, a prescription medication. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VENCLEXTA 100 MG TABLET UU 120S, a specialty pharmaceutical product. The order has a potential value of $26,640.45 and a completion date of March 19, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA as the primary vehicle for delivering pharmaceutical products...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Medical to AmerisourceBergen Drug Corp. The contract has a ceiling value of $17,760.30 and is for the delivery of 4565892142 VENCLEXTA 100 MG TABLET UU 120S, a specialty pharmaceutical product. The contract has an ultimate completion date of October 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this firm fixed-price delivery order contract to supply this critical medication to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,162.04 firm fixed-price contract is for the delivery of the prescription medication VENCLEXTA 50 MG TABLET UD 7S. The award does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of June 9, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX3ZX
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VENCLEXTA 100 MG TABLET (120 count). The $17,760.30 firm fixed price contract has a completion date of November 8, 2024 and does not utilize any set-aside designations. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceuticals and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 1/17/25, 9:13 AM